Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Nerve Care (Neuropathy) Articles
Popular Nerve Care (Neuropathy) Articles
Highly Recommended Nerve Care (Neuropathy) Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
The Mind Boggles
The penalties levied against Eli Lilly include a $515 million fine, the largest criminal fine ever imposed on an individual corporation in the history of U.S. criminal prosecution, the Justice Department said.
Eli Lilly and Company, Indianapolis, agreed to pay $1.4 billion and plead guilty to promoting its antipsychotic medication Zyprexa as a treatment for dementia when it was not approved for that use by the FDA, according to the Justice Department.
The penalties for the drugmaker include a $515 million fine, the largest criminal fine ever imposed on an individual corporation in the history of U.S. criminal prosecution, said the Justice Department in a press release. The company also agreed to forfeit $100 million. According to a news release from Eli Lilly, the company agreed to plead guilty to one misdemeanor criminal charge for the off-label promotion of Zyprexa as treatment of dementia between September 1999 and March 2001.
The company also copped to an almost $800 million civil settlement with the federal government and says it will resolve False Claims Act claims and related claims. In a modernhealthcare.com press release, Eli Lilly said the company "disagrees with and does not admit to the civil allegations."
The guilty plea and settlement must be approved by U.S. District Court.
In another story of costly alleged misbehavior, UnitedHealth will pay $350 million to settle a class-action lawsuit brought by the American Medical Association on behalf of physicians and patients. The lawsuit alleged that the company's health plans used flawed data administered by its subsidiary Ingenix to justify low reimbursement for out-of-network care.
The AMA argued that UnitedHealth's rate-setting practice violated the Employee Retirement Income Security Act, the Racketeer Influenced and Corrupt Organizations Act, and antitrust law. The proposed agreement contains no admission of wrongdoing, and the proposed settlement is subject to court approval.
New York Attorney General Andrew Cuomo said in press releases that he will continue to look into similar practices by UnitedHealth's peers.
Source: ModernHealthCare.com
Categories: Legal, Nerve Care (Neuropathy), Professional Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Zyprexa has generated a lot of bad press for Eli Lilly and they still have unresolved Zyprexa settlement claims.
Eli Lilly is 'reaping the whirlwind' for aggressive marketing of Zyprexa that has caused suffering and deaths.
--
Daniel Haszard 4 year Zyprexa patient who got diabetes from it.
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...